Pulmonx Corp (LUNG : NASDAQ)
Common Stock
$3.17
USD
+0.65 (25.60%)
Last updated: 2026-10-29
Follow LUNG
LUNG
Pulmonx Corp
WealthAwesomePerformance
1 Day
+25.60%
1 Week
+68.35%
1 Month
+59.85%
YTD
+153.20%
Key Statistics
Market Cap
$135.93M
52W High
$3.25
52W Low
$1.13
P/E Ratio
-
50 Day MA
$2.02
200 Day MA
$1.64
Beta
0.34
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/29/2026 | $2.61 | $3.25 | $2.53 | $3.17 | $3.17 | 5,307,602 |
| 10/28/2026 | $2.37 | $2.77 | $2.31 | $2.52 | $2.52 | 7,236,671 |
| 10/27/2026 | $1.99 | $2.02 | $1.92 | $1.98 | $1.98 | 354,192 |
| 10/26/2026 | $1.81 | $1.97 | $1.79 | $1.95 | $1.95 | 641,397 |
| 10/23/2026 | $1.80 | $1.88 | $1.79 | $1.83 | $1.83 | 227,800 |
| 10/22/2026 | $1.81 | $1.89 | $1.81 | $1.88 | $1.88 | 131,540 |
| 10/21/2026 | $1.82 | $1.86 | $1.82 | $1.83 | $1.83 | 176,674 |
| 10/20/2026 | $1.75 | $1.85 | $1.75 | $1.82 | $1.82 | 525,766 |
| 10/19/2026 | $1.80 | $1.80 | $1.75 | $1.75 | $1.75 | 220,309 |
| 10/16/2026 | $1.85 | $1.88 | $1.75 | $1.78 | $1.78 | 244,000 |
Analyst Price Targets
Based on 5 analysts covering LUNG · as of Oct 29, 2026
Wall Street analysts forecast LUNG stock price to rise 16.9% over the next 12 months.
Consensus
Buy4.20 / 5.00
Avg. Target
US$3.70
+16.9% Upside
Previously US$3.40 on Oct 5, 2026
Current Price
US$3.17
Last close
Analyst Breakdown (5 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LUNG's historical volatility
30-Day Vol
107.1%
Annualized
90-Day Vol
106.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$3.78
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$3.36 | US$2.32 – US$4.86 |
| 60 trading days | US$3.57 | US$2.11 – US$6.01 |
| 90 trading days | US$3.78 | US$2.00 – US$7.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Pulmonx Corp
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Financials
- Revenue (TTM)
- $88.78M
- EBITDA
- $-38.41M
- Profit Margin
- -47.93%
- ROE (TTM)
- -90.31%
- EPS (Diluted)
- -1.01
- Book Value
- 0.79
Classification
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Group
- Health Care Equipment & Services
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About LUNG.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| PCLA | PicoCELA Inc. American Depositary Shares | $11.10 | +86.09% |
| GENVR | Gen Digital Inc. Contingent Value Rights | $1.75 | +65.09% |
| NCPL | Netcapital Inc | $1.78 | +61.82% |
| INLF | INLIF LIMITED Ordinary Shares | $0.27 | +47.22% |
| XCH | XCHG Limited American Depositary Share | $3.46 | +41.80% |
| AMPGZ | Amplitech Group, Inc. Series B Right | $0.05 | +40.80% |
| SGLY | Singularity Future Technology Ltd | $0.50 | +40.17% |
| JFIN | Jiayin Group Inc | $1.72 | +37.60% |